Solesence, Inc. Common Stock (SLSN)
- Previous Close
3.1300 - Open
3.1500 - Bid 3.0100 x 200
- Ask 3.1500 x 100
- Day's Range
3.0100 - 3.2400 - 52 Week Range
1.2100 - 16.5600 - Volume
73,529 - Avg. Volume
118,390 - Market Cap (intraday)
216.619M - Beta (5Y Monthly) 0.77
- PE Ratio (TTM)
44.14 - EPS (TTM)
0.0700 - Earnings Date May 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company engages in engineered materials, formulation development, and commercial manufacturing. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients under the Solésence brand; skin health products, such as sunscreens and daily care products; and advanced material products, including architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, and medical diagnostics applications. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.
solesence.com98
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SLSN
View MorePerformance Overview: SLSN
Trailing total returns as of 5/5/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SLSN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SLSN
View MoreValuation Measures
Market Cap
219.42M
Enterprise Value
233.31M
Trailing P/E
44.71
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.89
Price/Book (mrq)
14.68
Enterprise Value/Revenue
4.46
Enterprise Value/EBITDA
38.50
Financial Highlights
Profitability and Income Statement
Profit Margin
8.09%
Return on Assets (ttm)
7.74%
Return on Equity (ttm)
50.27%
Revenue (ttm)
52.35M
Net Income Avi to Common (ttm)
4.24M
Diluted EPS (ttm)
0.0700
Balance Sheet and Cash Flow
Total Cash (mrq)
1.41M
Total Debt/Equity (mrq)
102.35%
Levered Free Cash Flow (ttm)
-3.44M